Accessibility Menu
 
Gerresheimer Ag logo

Gerresheimer Ag

(ETR) GXI

Current Price$20.74
Market Cap$717.05M
Since IPO (2007)-31%
5 Year-75%
1 Year-72%
1 Month+11%

Gerresheimer Ag Financials at a Glance

Market Cap

$717.05M

Revenue (TTM)

$2.25B

Net Income (TTM)

$23.35M

EPS (TTM)

$0.68

P/E Ratio

30.71

Dividend

$0.04

Beta (Volatility)

-0.05 (Low)

Price

$20.74

Volume

152,369

Open

$20.62

Previous Close

$20.74

Daily Range

$20.20 - $21.22

52-Week Range

$14.83 - $75.85

GXI News

No articles available.

GXI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gerresheimer Ag

Industry

Life Sciences Tools and Services

Employees

13,535

CEO

Dietmar Siemssen

Headquarters

Düsseldorf, 40468, DE

GXI Financials

Key Financial Metrics (TTM)

Gross Margin

27%

Operating Margin

8%

Net Income Margin

1%

Return on Equity

2%

Return on Capital

5%

Return on Assets

0%

Earnings Yield

3.26%

Dividend Yield

0.00%

Payout Ratio

14.49%

Stock Overview

Market Cap

$717.05M

Shares Outstanding

34.54M

Volume

152.37K

Short Interest

0.00%

Avg. Volume

371.86K

Financials (TTM)

Gross Profit

$607.76M

Operating Income

$197.47M

EBITDA

$405.97M

Operating Cash Flow

$240.33M

Capital Expenditure

$369.85M

Free Cash Flow

$129.51M

Cash & ST Invst.

$213.06M

Total Debt

$1.28B

Gerresheimer Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$560.68M

+12.5%

Gross Profit

$138.89M

-6.0%

Gross Margin

24.77%

N/A

Market Cap

$717.05M

N/A

Market Cap/Employee

$52.60K

N/A

Employees

13,632

N/A

Net Income

$12.70M

-146.7%

EBITDA

$74.08M

-26.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.16B

-91.8%

Accounts Receivable

$291.14M

+3.3%

Inventory

$511.38M

+37.5%

Long Term Debt

$1.71B

+160.8%

Short Term Debt

$604.90M

-0.1%

Return on Assets

0.50%

N/A

Return on Invested Capital

4.91%

N/A

Free Cash Flow

$17.73M

+263.9%

Operating Cash Flow

$85.55M

+20.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RHK.DERhoen-Klinikum AG
$12.30-1.60%
4LL.FTeladoc Health, Inc.
$4.81-1.42%
5CV.DECureVac N.V.
$3.91+0.72%
5CV.FCureVac N.V.
$3.91+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%
QQQInvesco QQQ Trust
$573.79-0.02%

Questions About GXI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.